RELMADA THERAPEUTICS INC (RLMD) Stock Balance Sheet
USA - NASDAQ:RLMD - US75955J4022 - Common Stock
1.67 USD
+0.02 (+1.21%)
1.67 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | N/A | 3.86M | 4.09M | 5.40M | 44.40M | |||
| Marketable Securities | 19.27M | 41.05M | 92.23M | 142.90M | 167.50M | |||
| Receivables | N/A | N/A | 0.00 | 500.00K | 100.00K | |||
| Other Current Assets | 474.60K | 886.50K | 1.19M | 4.00M | 11.30M | |||
| Total Current Assets | 21.09M | 45.80M | 97.51M | 152.90M | 223.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | N/A | N/A | N/A | N/A | 0.00 | |||
| Other Non-Current Assets | 22.00K | 22.00K | 43.10K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 21.90K | 22.00K | 43.10K | 0.00 | 0.00 | |||
| TOTAL ASSETS | 21.12M | 45.82M | 97.55M | 152.90M | 223.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 3.77M | 6.16M | 8.69M | 7.20M | 3.90M | |||
| Accounts Payable | 1.36M | 4.13M | 3.51M | 5.30M | 11.20M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 5.13M | 10.29M | 12.19M | 12.50M | 15.10M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 32.10K | 4.50K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 32.10K | 4.50K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 5.17M | 10.30M | 12.19M | 12.50M | 15.10M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -668.31M | -640.88M | -560.90M | -462.10M | -305.10M | |||
| Additional Paid In Capital | 684.22M | 676.37M | 646.23M | 602.50M | 513.30M | |||
| Common Shares | 33.20K | 30.20K | 30.10K | 0.00 | 0.00 | |||
| Shares Outstanding | 33.19M | 30.17M | 30.10M | 30.10M | 27.70M | |||
| Tangible Book Value per Share | 0.48 | 1.18 | 2.84 | 4.66 | 7.52 | |||
| Total Shareholders' Equity | 15.95M | 35.52M | 85.36M | 140.40M | 208.30M | |||
| TOTAL LIABILITIES AND EQUITY | 21.12M | 45.82M | 97.55M | 152.90M | 223.30M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 4.11 | 4.45 | 8.00 | 12.23 | 14.79 | |||
| Return On Assets (ROA) | -322.42% | -174.56% | -101.27% | -102.71% | -56.31% | |||
| Return On Equity (ROE) | -426.87% | -225.15% | -115.74% | -111.85% | -60.37% | |||
All data in USD , ROIC based on taxRate of 0.21